Biotech · Private company
Blade Therapeutics
Track this companyFree. Adds Blade Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- BLD-2660Phase 2 · Sars-CoV-2ClinicalTrials.gov · fetched Nov 12, 2026
- BLD-0409 750 mg Oral TabletPhase 1 · Drug Drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- Nintedanib 150 mg Oral CapsulePhase 1 · Drug Drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- Pirfenidone 267 mg Oral TabletPhase 1 · Drug Drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Dedicated Drug-Drug Interaction (DDI) Study in Healthy VolunteersPHASE1 · COMPLETED · started Oct 15, 2021ClinicalTrials.gov NCT04939467 · fetched Nov 12, 2026
- Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized SubjectsPHASE2 · COMPLETED · started May 4, 2020ClinicalTrials.gov NCT04334460 · fetched Nov 12, 2026